Mission
Meltzer E.O., Blaiss M.S., Derebery M.J., et al. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey. J Allergy Clin Immunol 124. (Suppl 3): S43-S70, 2009.
Hankin C.S., Cox, L., Bronstone A. The Health Economics of Allergen Immunotherapy. Immunol Allergy Clin North Amer. 31(2):325-41,2011.
Meltzer E.O.: Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 108. (1): S45-S53, 2001.
Allergen immunotherapy: A practice parameter third update
Cox, LindaCalabria, ChristopherBernstein, David I. et al.
Journal of Allergy and Clinical Immunology , Volume 127 , Issue 1 , S1 - S55 (https://www.jacionline.org/article/S0091-6749(10)01503-4/fulltext)
Vision
Allergen immunotherapy: Much more than a shot in the dark
Apter, Andrea J.
Journal of Allergy and Clinical Immunology , Volume 131 , Issue 4 , 1092 - 1093 (https://www.jacionline.org/article/S0091-6749(13)00258-3/fulltext)
​
International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics
Jutel, Marek et al.
Journal of Allergy and Clinical Immunology , Volume 137 , Issue 2 , 358 - 368 (https://www.jacionline.org/article/S0091-6749(15)03114-0/fulltext)
Schaffer FM, Naples AR, Ebeling M, Hulsey TC, Garner LM. The safety of self-administered allergen immunotherapy during the buildup and maintenance phases. Int Forum Allergy Rhinol. 2015;5:149–156.
​
​
​
https://stagrallergy.com/resources/
​
​
